Markets:

Overview

News

Currencies

International

Treasuries

Genprex, Inc. - Common Stock (NQ:GNPX)

0.7500 -0.0380 (-4.82%)

Streaming Delayed Price Updated: 9:47 AM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Genprex, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Opens Acclaim-2 Clinical Trial for Patient Enrollment

March 31, 2022

Via Investor Brand Network

Genprex Announces the Opening for Enrollment of its Phase 1/2 Acclaim-2 Clinical Trial of REQORSA™ Immunogene Therapy in Combination With Keytruda® to Treat Non-Small Cell Lung Cancer

March 31, 2022

From Genprex, Inc.

Via Business Wire

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at 2022 BIO Europe Spring Investor Conference

March 23, 2022

Via Investor Brand Network

Genprex to Participate in Upcoming Investor Conference in March

March 23, 2022

From Genprex, Inc.

Via Business Wire

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Dosing of First Patient in Acclaim-1 Clinical Trial

March 02, 2022

Via Investor Brand Network

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Participate at February Investor Conferences

February 09, 2022

Via Investor Brand Network

Genprex to Present at Upcoming Investor Conferences Highlighting its Gene Therapies for Cancer and Diabetes

February 09, 2022

From Genprex, Inc.

Via Business Wire

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Positioned to Expand Oncology Programs, Further Explore Use of ONCOPREX(R) Nanoparticle Delivery System

January 27, 2022

Via Investor Brand Network

Preclinical Data Show Potential for Use of Genprex’s ONCOPREX® Nanoparticle Delivery System in Treating Colon Cancer

January 27, 2022

From Genprex, Inc.

Via Business Wire

18 Stocks Moving in Wednesday's Pre-Market Session ↗

January 26, 2022

Gainers Exicure, Inc. (NASDAQ: XCUR) rose 41.1% to $0.23 in pre-market trading after gaining around 4% on Tuesday. Barfresh Food Group, Inc. (NASDAQ: BRFH) shares rose 31.7% to $...

Via Benzinga

48 Biggest Movers From Yesterday ↗

January 14, 2022

Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58...

Via Benzinga

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Accelerate Opening of Acclaim-1 Clinical Trial Sites

January 10, 2022

Via Investor Brand Network

Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer

January 10, 2022

From Genprex, Inc.

Via Business Wire

50 Biggest Movers From Yesterday ↗

January 06, 2022

Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 05, 2022

Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...

Via Benzinga

34 Stocks Moving In Wednesday's Mid-Day Session ↗

January 05, 2022

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights to novel mRNA biomarkers. Data Storage...

Via Benzinga

Genprex to Participate in January Investor and Healthcare Conferences to Highlight Company’s Gene Therapies in Cancer and Diabetes

January 05, 2022

From Genprex, Inc.

Via Business Wire

45 Biggest Movers From Yesterday ↗

January 05, 2022

Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 04, 2022

Gainers Hoth Therapeutics (NASDAQ:

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

January 04, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...

Via Benzinga

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Oncology R&D Pipeline to Include Small Cell Lung Cancer

January 04, 2022

Via Investor Brand Network

Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer

January 04, 2022

From Genprex, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 04, 2022

Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

61 Biggest Movers From Yesterday ↗

January 04, 2022

Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 03, 2022

Gainers Indaptus Therapeutics (NASDAQ:INDP

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 03, 2022

Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million...

Via Benzinga

CCL Stock: Why Carnival Is Cruising Higher Despite the CDC’s Covid Call ↗

January 03, 2022

Carnival (CCL) stock is heading higher on Monday despite recent concerns about the Covid-19 Omicron variant and CDC warnings.

Via InvestorPlace

TSM Stock: What Investors Are Saying About the Taiwan Semiconductor Breakout Today ↗

January 03, 2022

Taiwan Semiconductor (TSM) stock is getting a nice boost today alongside heavy trading even without any news surrounding the company today.

Via InvestorPlace

Dow Flat as Tesla Lifts Tech, Autos ↗

January 03, 2022

The Dow Jones Industrial Average is flat midday, as it cools off from this morning's burst higher. Both the S&P 500 Index and Nasdaq Composite are more comfortably in the black.

Via Talk Markets

GNPX Stock: 5 Things to Know as Genprex Rockets Higher ↗

January 03, 2022

Shares of GNPX stock are soaring higher after the FDA granted fast track designation (FTD) for the company's lead drug candidate, REQORSA.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.